selected scholarly activity
-
conferences
- Clinical Outcome and Treatment-Related Mortality in Patients with Acute Myeloid Leukemia Treated at the Uganda Cancer Institute. Blood. 8940-8941. 2022
- Malaria parasitemia among blood donors in Uganda. Transfusion. 955-964. 2020
- How low can you go: What is the safe threshold for platelet transfusions in patients with hematologic malignancy in sub-Saharan Africa.. PLoS ONE. e0211648. 2019
-
journal articles
- Advance Care Planning and palliative care for patients with advanced cancer in Uganda. Zeitschrift für Evidenz, Fortbildung und Qualitat im Gesundheitswesen. 180:29-35. 2023
-
SARS‐CoV ‐2 seroprevalence among blood donors in Uganda: 2019–2022. Transfusion. 63:1354-1365. 2023 - One-Year Survival and Prognosticators of Adults With Acute Leukemia at the Uganda Cancer Institute. JCO Global Oncology. 9:e2200244. 2023
- Virologic Nonsuppression Among Patients With HIV Newly Diagnosed With Cancer at Uganda Cancer Institute: A Cross-Sectional Study. JCO Global Oncology. 9:e2200262. 2023
- The Mirasol Evaluation of Reduction in Infections Trial (MERIT): study protocol for a randomized controlled clinical trial. Trials. 23:257. 2022
- Cytoreductive surgery for giant locally advanced intra-abdominal tumors in Uganda. Journal of Surgical Case Reports. 2022:rjac178. 2022
- Efficacy of convalescent plasma for treatment of COVID-19 in Uganda. BMJ Open Respiratory Research. 8:e001017-e001017. 2021
- Global reporting of pulmonary embolism–related deaths in the World Health Organization mortality database: Vital registration data from 123 countries. Research and Practice in Thrombosis and Haemostasis. 5:e12520-e12520. 2021
- Characteristics and outcomes of patients with multiple myeloma at the Uganda Cancer Institute. African Health Sciences. 21:67-74. 2021
- Cancer and palliative care in COVID-19 and other challenging situations – highlights from the Uganda Cancer Institute – Palliative Care Association of Uganda 3rd Uganda Conference on Cancer and Palliative Care, 23–24 September 2021, held in Kampala, Uganda and virtually. ecancermedicalscience. 15:1333. 2021
- Feasibility of collecting and processing of COVID-19 convalescent plasma for treatment of COVID-19 in Uganda. PLoS ONE. 16:e0252306-e0252306. 2021
- Survival of patients with cancer associated thrombosis at the Uganda Cancer Institute. ecancermedicalscience. 15:1212. 2021
- Transfusion Challenges in Patients with Hematological Malignancies in Sub-Saharan Africa: A Prospective Observational Study from the Uganda Cancer Institute. Scientific Reports. 10:2825. 2020
- Bacteremia in febrile cancer patients in Uganda. BMC Research Notes. 12:464. 2019
- Understanding data and information needs for palliative cancer care to inform digital health intervention development in Nigeria, Uganda and Zimbabwe: protocol for a multicountry qualitative study. BMJ Open. 9:e032166-e032166. 2019
- How low can you go: What is the safe threshold for platelet transfusions in patients with hematologic malignancy in sub-Saharan Africa. PLoS ONE. 14:e0211648-e0211648. 2019
- Towards universal coverage—highlights from the 2nd Uganda Conference on Cancer and Palliative Care, 5–6 September 2019, Kampala, Uganda. ecancermedicalscience. 13:976. 2019
- Survey to Assess Knowledge and Reported Practices Regarding Blood Transfusion Among Cancer Physicians in Uganda. Journal of Global Oncology. 4:1-12. 2018
- Impact of World Thrombosis Day campaign. Research and Practice in Thrombosis and Haemostasis. 1:138-141. 2017
- Platelet transfusion therapy in sub‐Saharan Africa: bacterial contamination, recipient characteristics, and acute transfusion reactions. Transfusion. 56:1951-1959. 2016
- Transfusion Medicine in Sub-Saharan Africa: Conference Summary. Transfusion Medicine Reviews. 29:195-204. 2015
- Supportive and palliative care for metastatic breast cancer: Resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. Breast. 22:616-627. 2013
-
Cytoadherence in paediatric malaria:
ABO blood group,CD 36, andICAM 1 expression and severeP lasmodium falciparum infection. British Journal of Haematology. 159:223-236. 2012